Literature DB >> 15920197

The effects of intravenous lidocaine on pain during injection of medium- and long-chain triglyceride propofol emulsions.

Woon Si Yew1, Shin Yuet Chong, Kian Hian Tan, Meng Huat Goh.   

Abstract

Propofol formulated in medium- and long-chain triglycerides (MCT/LCT) is thought to cause less pain on injection. In this study we sought to determine if adding lidocaine to propofol-MCT/LCT is more effective in decreasing pain compared with propofol-MCT/LCT alone or conventional propofol-lidocaine mixtures. Seventy-five patients were randomized into three groups. Group A received conventional propofol-lidocaine mixtures with 20 mg lidocaine, group B received propofol-MCT/LCT with saline, and group C received propofol-MCT/LCT with 20 mg lidocaine. The incidence of pain was 24% in groups A and B and 4% in group C. The number needed to treat to prevent pain was 5. We conclude that propofol-MCT/LCT-lidocaine mixtures significantly reduce pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920197     DOI: 10.1213/01.ANE.0000151718.58709.0B

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

Review 1.  Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults.

Authors:  Pramote Euasobhon; Sukanya Dej-Arkom; Arunotai Siriussawakul; Saipin Muangman; Wimonrat Sriraj; Porjai Pattanittum; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2016-02-18

2.  Comparison of the preventive effects of pretreatment of lidocaine with a tourniquet and a premixed injection of lidocaine on propofol-LCT/MCT injection pain.

Authors:  Hyo Jin Byon; Kil Woo Lee; Hee Yong Shim; Jang Ho Song; Jong Kwon Jung; Young Deog Cha; Doo Ik Lee
Journal:  Korean J Anesthesiol       Date:  2014-02-28

3.  Medium- and long-chain triglyceride propofol reduces the activity of acetyl-coenzyme A carboxylase in hepatic lipid metabolism in HepG2 and Huh7 cells.

Authors:  Li-Yuan Wang; Jing Wu; Ya-Fen Gao; Duo-Mao Lin; Jun Ma
Journal:  Korean J Physiol Pharmacol       Date:  2020-12-20       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.